Anonymization of Health Insurance Claims Data for Medication Safety Assessments
Studies in Health Technology and Informatics · 2025
DOI: 10.3233/shti251407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, 2025. Verfasst von Mehmed Halilovic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Informatics Group, Berlin Institute of Health atCharité, Germany. Hauptthemen laut MEDLINE: Data Anonymization, Confidentiality, Insurance Claim Review, Insurance, Health. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Medikationssicherheit
Abstract (Originalsprache)
Introduction
The re-use of health insurance claims data for research purposes can provide valuable insights to improve patient care. However, as health data is often highly sensitive and subject to strict regulatory frameworks, the privacy of individuals must be protected. Anonymization is a common approach to do so, but finding an effective strategy is challenging due to an inherent trade-off between privacy protection and data utility. A structured approach is needed to balance these objectives and guide the selection of appropriate anonymization strategies.
Methods
In this paper, we present a systematic evaluation of twelve anonymization strategies applied to German health insurance claims data that has previously been used in a drug safety study. The dataset consisted of 1727 records and 45 variables. Based on a structured threat modeling, we compare a conservative and a threat modeling-based approach, each with six different privacy models and risk thresholds using the ARX Data Anonymization Tool. We assess general data utility and empirically evaluate residual privacy risks using both the Anonymeter framework and a membership inference attack.
Results
Our results show that conservative anonymization ensures strong privacy protection but reduces data utility. In contrast, threat modeling retains more utility while still providing acceptable privacy under moderate thresholds.
Conclusion
The proposed process enables a systematic comparison of privacy-utility trade-offs and can be adapted to other medical datasets. Our findings highlight the importance of context-specific anonymization strategies and empirical risk evaluation to guide anonymized data sharing in healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Informatics Group, Berlin Institute of Health atCharité, Germany.
- InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Deutschland.
- Forschungsdatenzentrum Gesundheit, Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Deutschland.
Zitieren
APA
Halilovic, M., Otte, K., Meurers, T., Alibone, M., Ludwig, M., Riedel, N., Wolter, S., Kühnel, L., Hess, S., & Prasser, F. (2025). Anonymization of Health Insurance Claims Data for Medication Safety Assessments. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti251407
Vancouver
Halilovic M, Otte K, Meurers T, Alibone M, Ludwig M, Riedel N, et al. Anonymization of Health Insurance Claims Data for Medication Safety Assessments. Studies in Health Technology and Informatics. 2025. doi:10.3233/shti251407
BibTeX
@article{Halilovic2025,
author = {Halilovic, Mehmed and Otte, Karen and Meurers, Thierry and Alibone, Marco and Ludwig, Marion and Riedel, Nico and Wolter, Steven and Kühnel, Lisa and Hess, Steffen and Prasser, Fabian},
title = {Anonymization of Health Insurance Claims Data for Medication Safety Assessments},
journal = {Studies in Health Technology and Informatics},
year = {2025},
doi = {10.3233/shti251407}
}
EUVIMED